Blastic Transformation of Chronic Myeloid Leukemia

2 clinical trials · Condition

Record	Firm	Date
Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML (NCT07493408)	The University of Hong Kong	2026-03-30
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances (NCT05092451)	M.D. Anderson Cancer Center	2022-11-01

Every clearance here is in the API, with alerts when new ones post.